DK1517913T3 - A Mycobacterium tuberculosis coding sequence for expression of heterologous proteins - Google Patents
A Mycobacterium tuberculosis coding sequence for expression of heterologous proteinsInfo
- Publication number
- DK1517913T3 DK1517913T3 DK00970619T DK00970619T DK1517913T3 DK 1517913 T3 DK1517913 T3 DK 1517913T3 DK 00970619 T DK00970619 T DK 00970619T DK 00970619 T DK00970619 T DK 00970619T DK 1517913 T3 DK1517913 T3 DK 1517913T3
- Authority
- DK
- Denmark
- Prior art keywords
- expression
- mycobacterium tuberculosis
- coding sequence
- polypeptide
- heterologous proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates generally to nucleic acid and amino acid sequences of a fusion polypeptide comprising a Mycobacterium tuberculosis polypeptide, and a heterologous polypeptide of interest, expression vectors and host cells comprising such nucleic acids, and methods for producing such fusion polypeptides. In particular, the invention relates to materials and methods of using such M. tuberculosis sequence as a fusion partner to facilitate the stable and high yield expression of recombinant heterologous polypeptides of both eukaryotic and prokaryotic origin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15858599P | 1999-10-07 | 1999-10-07 | |
PCT/US2000/027652 WO2001025401A2 (en) | 1999-10-07 | 2000-10-06 | A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1517913T3 true DK1517913T3 (en) | 2007-06-18 |
Family
ID=22568818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00970619T DK1517913T3 (en) | 1999-10-07 | 2000-10-06 | A Mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060040356A1 (en) |
EP (1) | EP1517913B9 (en) |
JP (1) | JP2003527830A (en) |
AT (1) | ATE354663T1 (en) |
AU (1) | AU779846B2 (en) |
CA (1) | CA2386854A1 (en) |
CY (1) | CY1106593T1 (en) |
DE (1) | DE60033583T2 (en) |
DK (1) | DK1517913T3 (en) |
ES (1) | ES2282142T3 (en) |
PT (1) | PT1517913E (en) |
WO (1) | WO2001025401A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2374620T3 (en) * | 2000-06-20 | 2012-02-20 | Corixa Corporation | ANTIGEN MTB32A OF MYCOBACTERIUM TUBERCULOSIS WITH THE ACTIVE ACTIVE SITE AND FUSION PROTEINS OF THEMSELVES. |
SG159554A1 (en) | 2004-11-16 | 2010-03-30 | Crucell Holland Bv | Multivalent vaccines comprising recombinant viral vectors |
CN104292089B (en) * | 2014-09-30 | 2016-01-13 | 大连九信生物化工科技有限公司 | The synthesis technique of the chloro-1 '-chloracetyl cyclopropane of a kind of 1- |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566072B1 (en) * | 1995-05-31 | 2003-05-20 | Washington University | Mammaglobin, a secreted mammary-specific breast cancer protein |
EP0850305B1 (en) * | 1995-09-01 | 2006-04-26 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
US6592877B1 (en) * | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6458366B1 (en) * | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
US20020068285A1 (en) * | 1996-01-11 | 2002-06-06 | Frudakis Tony N. | Compositions and methods for the therapy and diagnosis of breast cancer |
EP0925364B1 (en) * | 1996-09-06 | 2002-10-23 | Bioteknologisk Institut | A lactic acid bacterial regulatable expression system |
AU4750597A (en) * | 1996-10-11 | 1998-05-11 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
US6627198B2 (en) * | 1997-03-13 | 2003-09-30 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis antigens and their uses |
US6544522B1 (en) * | 1998-12-30 | 2003-04-08 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
US6350456B1 (en) * | 1997-03-13 | 2002-02-26 | Corixa Corporation | Compositions and methods for the prevention and treatment of M. tuberculosis infection |
FR2767337B1 (en) * | 1997-08-14 | 2002-07-05 | Pasteur Institut | NUCLEIC SEQUENCES OF POLYPEPTIDES EXPORTED FROM MYCOBACTERI ES, VECTORS COMPRISING THEM AND APPLICATIONS TO DIAGNOSIS AND THE PREVENTION OF TUBERCULOSIS |
CA2302779C (en) * | 1997-09-16 | 2010-02-02 | Oregon Health Sciences University | Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
AU753995B2 (en) * | 1998-04-07 | 2002-10-31 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
US6448234B1 (en) * | 1998-12-08 | 2002-09-10 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US6509448B2 (en) * | 1999-06-30 | 2003-01-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7311922B1 (en) * | 1999-10-07 | 2007-12-25 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
US7009042B1 (en) * | 1999-10-07 | 2006-03-07 | Corixa Corporation | Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
WO2001034802A2 (en) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
KR20030016217A (en) * | 2000-01-14 | 2003-02-26 | 코릭사 코포레이션 | Compositions and methods for the therapy and diagnosis of prostate cancer |
JP2004504808A (en) * | 2000-03-27 | 2004-02-19 | コリクサ コーポレイション | Compositions and methods for treatment and diagnosis of prostate cancer |
ES2374620T3 (en) * | 2000-06-20 | 2012-02-20 | Corixa Corporation | ANTIGEN MTB32A OF MYCOBACTERIUM TUBERCULOSIS WITH THE ACTIVE ACTIVE SITE AND FUSION PROTEINS OF THEMSELVES. |
-
2000
- 2000-10-06 AU AU79972/00A patent/AU779846B2/en not_active Ceased
- 2000-10-06 AT AT00970619T patent/ATE354663T1/en not_active IP Right Cessation
- 2000-10-06 WO PCT/US2000/027652 patent/WO2001025401A2/en active IP Right Grant
- 2000-10-06 EP EP00970619A patent/EP1517913B9/en not_active Expired - Lifetime
- 2000-10-06 DE DE60033583T patent/DE60033583T2/en not_active Expired - Fee Related
- 2000-10-06 DK DK00970619T patent/DK1517913T3/en active
- 2000-10-06 CA CA002386854A patent/CA2386854A1/en not_active Abandoned
- 2000-10-06 ES ES00970619T patent/ES2282142T3/en not_active Expired - Lifetime
- 2000-10-06 PT PT00970619T patent/PT1517913E/en unknown
- 2000-10-06 JP JP2001528556A patent/JP2003527830A/en not_active Withdrawn
-
2005
- 2005-09-07 US US11/222,451 patent/US20060040356A1/en not_active Abandoned
-
2007
- 2007-05-14 CY CY20071100656T patent/CY1106593T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001025401A9 (en) | 2002-09-26 |
WO2001025401A3 (en) | 2005-02-03 |
EP1517913A2 (en) | 2005-03-30 |
JP2003527830A (en) | 2003-09-24 |
CA2386854A1 (en) | 2001-04-12 |
AU7997200A (en) | 2001-05-10 |
PT1517913E (en) | 2007-05-31 |
DE60033583D1 (en) | 2007-04-05 |
CY1106593T1 (en) | 2012-01-25 |
WO2001025401A2 (en) | 2001-04-12 |
EP1517913B1 (en) | 2007-02-21 |
EP1517913B9 (en) | 2007-08-29 |
DE60033583T2 (en) | 2007-09-13 |
EP1517913A4 (en) | 2005-09-14 |
ES2282142T3 (en) | 2007-10-16 |
AU779846B2 (en) | 2005-02-17 |
ATE354663T1 (en) | 2007-03-15 |
US20060040356A1 (en) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0722461A4 (en) | Expression of fusion polypeptides transported out of the cytoplasm without leader sequences | |
TW200732472A (en) | Method for the recombinant expression of a polypeptide | |
CA2443365A1 (en) | Methods for the recombinant production of antifusogenic peptides | |
IL134968A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
HK1114636A1 (en) | 1l-17 homologous polypeptides and therapeutic uses thereof | |
HK1071375A1 (en) | Egviii endoglucanase and nucleic acids encoding the same egviii | |
DK1012293T3 (en) | Compounds for immunotherapy and diagnosis of tuberculosis and methods for their use | |
DK1133565T3 (en) | Generation of specific binding partners for (poly) peptides encoded by genomic DNA fragments or ESTs | |
WO1999028462A3 (en) | Polypeptides and nucleic acids encoding the same | |
WO1994018332A3 (en) | Anthrax toxin fusion proteins and uses thereof | |
EP0963435A4 (en) | Methods for production of proteins | |
KR100468977B1 (en) | Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same | |
BR0009393A (en) | Polypeptide, isolated nucleic acid sequence, nucleic acid construct, recombinant expression vector, recombinant host cell, method for producing polypeptide, use of polypeptide, and detergent composition | |
ID27206A (en) | GENERATION OF GENA MULTIPLE PRODUCTS FROM SIMERIC FUSION PROTEINS THROUGH THE DECISION OF UBIKUITUS ENDOPROTEASE | |
ATE540981T1 (en) | SOLUBLE FUSION PROTEINS CONTAINING HETEROLOGUE POLYPEPTIDES | |
DK1609863T3 (en) | Secreted polypeptides and transmembrane polypeptides as well as nucleic acids encoding them | |
MX2023002413A (en) | Immunogenic coronavirus fusion proteins and related methods. | |
DK1517913T3 (en) | A Mycobacterium tuberculosis coding sequence for expression of heterologous proteins | |
DE69735242D1 (en) | N-TERMINAL EXTENDED PROTEIN EXPRESSED IN YEAST | |
WO1999002708A8 (en) | Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein | |
CA2327524A1 (en) | Method of controlling cleavage by ompt protease | |
WO2004016748A3 (en) | Biotinylation of proteins | |
SE0303093D0 (en) | Expression vector, host cell and method for producing fusion proteins | |
DE60207157D1 (en) | Purification method based on the binding of enzymes and labeled peptides | |
RU2006114756A (en) | METHOD FOR SPLITTING POLYEPEPTIDES USING THE OMRT PROTEASE OPTION |